Released: April 8, 2011 
Type: Workshop Summary
Topic: Biomedical and Health Research
Activity: Forum on Drug Discovery, Development, and Translation
Board: Board on Health Sciences Policy
Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.
Many tuberculosis (TB) experts and health authorities believe that the majority of the world’s drug-resistant TB cases are undiagnosed and untreated. These strains of the airborne disease are resistant to standard antibiotic treatment and present significant challenges in controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of drug-resistant TB has been exacerbated by social, political, and economic upheavals. The size of the country presents additional problems in monitoring its occurrence and controlling its spread.
The IOM Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences, held a workshop May 26-27, 2010, in Moscow—the second in a series of international meetings designed to gather information from experts on the threat of drug-resistant TB and ways to combat it. Representatives from the Russian public health community shared their experiences in fighting drug-resistant TB, and participants discussed lessons learned, best practices, and new approaches that can be used worldwide to treat and prevent TB.
http://www.iom.edu/Reports/2011/New-Profile-of-Drug-Resistant-Tuberculosis-in-Russia.aspx?utm_medium=etmail&utm_source=Institute%20of%20Medicine&utm_campaign=IOM+Report+Alert+-+REVISED+for+Outlook+07+-+TEST&utm_content=New%20Reports&utm_term=Non-profit
Type: Workshop Summary
Topic: Biomedical and Health Research
Activity: Forum on Drug Discovery, Development, and Translation
Board: Board on Health Sciences Policy
Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.
Many tuberculosis (TB) experts and health authorities believe that the majority of the world’s drug-resistant TB cases are undiagnosed and untreated. These strains of the airborne disease are resistant to standard antibiotic treatment and present significant challenges in controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of drug-resistant TB has been exacerbated by social, political, and economic upheavals. The size of the country presents additional problems in monitoring its occurrence and controlling its spread.
The IOM Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences, held a workshop May 26-27, 2010, in Moscow—the second in a series of international meetings designed to gather information from experts on the threat of drug-resistant TB and ways to combat it. Representatives from the Russian public health community shared their experiences in fighting drug-resistant TB, and participants discussed lessons learned, best practices, and new approaches that can be used worldwide to treat and prevent TB.
http://www.iom.edu/Reports/2011/New-Profile-of-Drug-Resistant-Tuberculosis-in-Russia.aspx?utm_medium=etmail&utm_source=Institute%20of%20Medicine&utm_campaign=IOM+Report+Alert+-+REVISED+for+Outlook+07+-+TEST&utm_content=New%20Reports&utm_term=Non-profit
No comments:
Post a Comment